Advances in Fluorescence Image-Guided Surgery | Dr. Daniel Gould

Dr. Daniel Gould co-authored this review published in Annals of Translational Medicine, examining advances in fluorescence image-guided surgery and the technologies being developed to help surgeons visualize important tissues and structures during an operation. 

Fluorescence-guided surgery uses specialized imaging agents and optical technologies to highlight specific tissues in real time. By making structures more visually distinct during an operation, these techniques have the potential to help surgeons identify anatomy, differentiate diseased from healthy tissue, and make more informed decisions while operating.

The review explores the development of fluorescent contrast agents and imaging systems across several surgical specialties. These technologies can be designed to target particular biological characteristics, potentially allowing surgeons to visualize tumors, blood vessels, lymphatic structures, and other tissues that may be difficult to distinguish using conventional vision alone.

Dr. Gould and his co-authors also discuss the potential role of fluorescence imaging in cancer surgery. More precise visualization of tumor boundaries may help surgeons identify residual disease while preserving surrounding healthy tissue, supporting the broader goal of achieving effective resection with greater anatomical precision.

The authors highlight that fluorescence image-guided surgery was still an evolving field, with continued research needed to refine imaging agents, improve targeting, and translate emerging technologies into routine clinical practice.

The review provides an overview of how advances in molecular imaging and surgical technology may ultimately give surgeons additional real-time information in the operating room, expanding the possibilities for more precise and image-informed surgery.